Literature DB >> 31431194

Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.

Bing Liu1, Shimeng Pan1, Yang Xiao1, Qianqian Liu1, Jingchao Xu2, Li Jia3.   

Abstract

In the publication of this article [1], there is an error in Fig. 5C (panel 4, group of InmiR-26a + silinc01296 in SW620). The revised Fig. 5 which includes 5C has now been included in this correction.

Entities:  

Year:  2019        PMID: 31431194      PMCID: PMC6702711          DOI: 10.1186/s13046-019-1367-9

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


Correction to: J Exp Clin Cancer Res https://doi.org/10.1186/s13046-018-0994-x In the publication of this article [1], there is an error in Fig. 5c (panel 4, group of InmiR-26a + silinc01296 in SW620). The revised Fig. 5 which includes 5C has now been included in this correction.
Fig. 5

The effect of co-expression linc01296 and miR-26a on CRC progression. a Flow cytometry showed O-linked glycosylation level detected by fluorescein isothiocyanate (FITC)-conjugated VVA on the cell surface of transfected CRC cells. b CCK8 assay showed variant growth rate of transfected CRC cells. c Colony formation assay detected proliferative formation with different treated CRC cells. d Aggressiveness changed was determined by transwell assay, the migratory and invasive cells were counted. e CRC cells were treated with 5-FU, and the cell viability was detected by CCK8 assay. f IC50 values of treated CRC cells were calculated. g The effect of 5-FU on CRC cell proliferation was determined by colony formation assay. h Flow cytometry showed the apoptosis rate of transfected CRC cells in response to 5-FU. i FITC-VVA on transfected CRC cells surface was detected by flow cytometry. j The growth curves of transfected CRC cells were pictured after conducting CCK8 assay. k Proliferation of treated CRC cells was examined by colony formation assay. l Migration and invasion were observed in transfected SW620 cells. m With 5-FU treatment, the cell viability was determined by CCK8 assay. n The IC50 values were subsequently calculated. o 5-FU resistant CRC cells were transfected with linc01296 or miR-26a mimic, and the colony formation was counted in response to 5-FU. p The apoptosis rate of transfected CRC cells was detected after 5-FU treatment by flow cytometry. The data were means ± SD of three independent assays (*P < 0.05)

The effect of co-expression linc01296 and miR-26a on CRC progression. a Flow cytometry showed O-linked glycosylation level detected by fluorescein isothiocyanate (FITC)-conjugated VVA on the cell surface of transfected CRC cells. b CCK8 assay showed variant growth rate of transfected CRC cells. c Colony formation assay detected proliferative formation with different treated CRC cells. d Aggressiveness changed was determined by transwell assay, the migratory and invasive cells were counted. e CRC cells were treated with 5-FU, and the cell viability was detected by CCK8 assay. f IC50 values of treated CRC cells were calculated. g The effect of 5-FU on CRC cell proliferation was determined by colony formation assay. h Flow cytometry showed the apoptosis rate of transfected CRC cells in response to 5-FU. i FITC-VVA on transfected CRC cells surface was detected by flow cytometry. j The growth curves of transfected CRC cells were pictured after conducting CCK8 assay. k Proliferation of treated CRC cells was examined by colony formation assay. l Migration and invasion were observed in transfected SW620 cells. m With 5-FU treatment, the cell viability was determined by CCK8 assay. n The IC50 values were subsequently calculated. o 5-FU resistant CRC cells were transfected with linc01296 or miR-26a mimic, and the colony formation was counted in response to 5-FU. p The apoptosis rate of transfected CRC cells was detected after 5-FU treatment by flow cytometry. The data were means ± SD of three independent assays (*P < 0.05)
  1 in total

1.  LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.

Authors:  Bing Liu; Shimeng Pan; Yang Xiao; Qianqian Liu; Jingchao Xu; Li Jia
Journal:  J Exp Clin Cancer Res       Date:  2018-12-14
  1 in total
  5 in total

1.  Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis.

Authors:  Ni Bai; Ying Ma; Jia Zhao; Bo Li
Journal:  Cancer Manag Res       Date:  2020-06-19       Impact factor: 3.989

2.  MiR-26a inhibits the inflammatory response of microglia by targeting HMGA2 in intracerebral hemorrhage.

Authors:  Jun Jin; Feng Zhou; Jie Zhu; Weixian Zeng; Yong Liu
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

3.  OIP5-AS1 contributes to tumorigenesis in hepatocellular carcinoma by miR-300/YY1-activated WNT pathway.

Authors:  Yu Wang; Lei Dou; Yun Qin; Huiyuan Yang; Peng Yan
Journal:  Cancer Cell Int       Date:  2020-09-09       Impact factor: 5.722

4.  SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.

Authors:  Taicheng Zhou; Lili Wu; Ning Ma; Fuxin Tang; Zhuomin Yu; Zhipeng Jiang; Yingru Li; Zhen Zong; Kunpeng Hu
Journal:  Cell Death Dis       Date:  2020-12-14       Impact factor: 8.469

5.  FTX contributes to cell proliferation and migration in lung adenocarcinoma via targeting miR-335-5p/NUCB2 axis.

Authors:  Xiaodong Huo; Huixing Wang; Bin Huo; Lei Wang; Kuo Yang; Jinhuan Wang; Lili Wang; Haitao Wang
Journal:  Cancer Cell Int       Date:  2020-03-23       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.